Latest Inflammatory bowel disease Stories
LONDON, January 22, 2015 /PRNewswire/ -- Report Details Treating Crohn's disease and ulcerative colitis - how to find R&D trends, opportunities and revenue
NEW YORK, Jan.
SGM-1019 is an oral small molecule inhibitor of a target identified by company's Microbiome Discovery Platform SOUTH SAN FRANCISCO, Jan.
LONDON, January 7, 2015 /PRNewswire/ -- ~ Shield seeks approval of Feraccru for the treatment of iron deficiency
One of the nation’s leading doctors is now offering to treat patients for life for one low fee instead of having to pay every time an appointment is scheduled. Ogunquit,
NEW YORK, Dec.
PTG-100, a Novel Peptide as an 'Oral Targeted Therapy' for Inflammatory Bowel Diseases MILPITAS, Calif., Dec.
CCFA highlights the now 1.6 million Americans with these autoimmune diseases with new social media campaign during Crohn's & Colitis Awareness Week December 1-7, 2014 NEW YORK, Dec.
One of the nation’s leading doctors has reached a new milestone while providing healing for thousands of patients over the past three decades. Ogunquit, Maine
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.